Tema Neuroscience and Mental Health ETF is a ETF series of Tema ETF Trust (series S000081543). Net assets $9.7M as of 2025-05-31.
Showing 15 of 45 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Vertex Pharmaceuticals Inc | — | $1.0M | 1046.11% |
| Regeneron Pharmaceuticals Inc | — | $630K | 648.28% |
| Alnylam Pharmaceuticals Inc | — | $604K | 621.63% |
| Argenx SE | — | $510K | 525.41% |
| Teva Pharmaceutical Industries | — | $484K | 498.72% |
| Neurocrine Biosciences Inc | — | $480K | 494.58% |
| Eli Lilly & Co | — | $404K | 415.53% |
| Crinetics Pharmaceuticals Inc | — | $399K | 410.52% |
| Biogen Inc | — | $325K | 334.28% |
| Stryker Corp | — | $305K | 314.45% |
| Catalyst Pharmaceuticals Inc | — | $283K | 291.79% |
| Ionis Pharmaceuticals Inc | — | $279K | 287.04% |
| Medtronic PLC | — | $247K | 254.31% |
| Axsome Therapeutics Inc | — | $245K | 252.00% |
| ACADIA Pharmaceuticals Inc | — | $229K | 235.37% |
| Report date | Net assets |
|---|---|
| 2025-05-31 | $9.7M |
| 2025-02-28 | $10.9M |
| 2024-11-30 | $11.5M |
| 2024-08-31 | $12.0M |
| 2024-05-31 | $10.8M |
| 2024-02-29 | $11.4M |